Atria Wealth Solutions Inc. Sells 32,912 Shares of Omega Healthcare Investors, Inc. $OHI

Atria Wealth Solutions Inc. decreased its stake in Omega Healthcare Investors, Inc. (NYSE:OHI - Free Report) by 60.0% in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 21,938 shares of the real estate investment trust's stock after selling 32,912 shares during the period. Atria Wealth Solutions Inc.'s holdings in Omega Healthcare Investors were worth $804,000 at the end of the most recent quarter.

Several other hedge funds also recently modified their holdings of the stock. Sequoia Financial Advisors LLC bought a new position in shares of Omega Healthcare Investors in the 2nd quarter valued at about $552,000. Yousif Capital Management LLC grew its holdings in shares of Omega Healthcare Investors by 1.2% in the 2nd quarter. Yousif Capital Management LLC now owns 106,779 shares of the real estate investment trust's stock valued at $3,913,000 after acquiring an additional 1,232 shares in the last quarter. CWM LLC grew its holdings in shares of Omega Healthcare Investors by 67.6% in the 2nd quarter. CWM LLC now owns 39,545 shares of the real estate investment trust's stock valued at $1,449,000 after acquiring an additional 15,947 shares in the last quarter. Vanguard Personalized Indexing Management LLC grew its holdings in shares of Omega Healthcare Investors by 11.7% in the 2nd quarter. Vanguard Personalized Indexing Management LLC now owns 30,922 shares of the real estate investment trust's stock valued at $1,133,000 after acquiring an additional 3,227 shares in the last quarter. Finally, Concurrent Investment Advisors LLC grew its holdings in Omega Healthcare Investors by 7.4% during the second quarter. Concurrent Investment Advisors LLC now owns 30,853 shares of the real estate investment trust's stock worth $1,131,000 after purchasing an additional 2,124 shares during the period. Institutional investors own 65.25% of the company's stock.

Omega Healthcare Investors Trading Up 1.8%

Shares of NYSE:OHI opened at $41.07 on Friday. Omega Healthcare Investors, Inc. has a 12-month low of $35.04 and a 12-month high of $44.42. The stock has a market cap of $12.12 billion, a PE ratio of 25.35, a P/E/G ratio of 1.92 and a beta of 0.70. The business has a 50 day moving average of $41.58 and a 200-day moving average of $38.89. The company has a quick ratio of 7.10, a current ratio of 7.10 and a debt-to-equity ratio of 0.96.

Omega Healthcare Investors (NYSE:OHI - Get Free Report) last issued its quarterly earnings data on Thursday, July 31st. The real estate investment trust reported $0.77 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.45 by $0.32. Omega Healthcare Investors had a return on equity of 9.78% and a net margin of 42.23%.The company had revenue of $235.60 million during the quarter, compared to analysts' expectations of $248.49 million. During the same quarter in the previous year, the company posted $0.71 earnings per share. The business's revenue was up 11.8% on a year-over-year basis. Omega Healthcare Investors has set its FY 2025 guidance at 3.040-3.070 EPS. As a group, equities research analysts forecast that Omega Healthcare Investors, Inc. will post 2.86 earnings per share for the current year.

Omega Healthcare Investors Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, August 15th. Stockholders of record on Monday, August 4th were issued a dividend of $0.67 per share. This represents a $2.68 dividend on an annualized basis and a dividend yield of 6.5%. The ex-dividend date was Monday, August 4th. Omega Healthcare Investors's payout ratio is currently 165.43%.

Insider Activity

In other news, Director Lisa Egbuonu-Davis sold 2,500 shares of the business's stock in a transaction that occurred on Friday, August 8th. The stock was sold at an average price of $40.16, for a total transaction of $100,400.00. Following the completion of the sale, the director owned 18,654 shares in the company, valued at $749,144.64. The trade was a 11.82% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. 1.50% of the stock is currently owned by corporate insiders.

Wall Street Analysts Forecast Growth

OHI has been the subject of a number of research analyst reports. Weiss Ratings reiterated a "buy (b)" rating on shares of Omega Healthcare Investors in a report on Wednesday, October 8th. Mizuho lifted their price target on Omega Healthcare Investors from $37.00 to $40.00 and gave the stock a "neutral" rating in a report on Thursday, September 11th. Cantor Fitzgerald initiated coverage on Omega Healthcare Investors in a report on Wednesday, October 1st. They set an "overweight" rating and a $50.00 price target for the company. Scotiabank lifted their price target on Omega Healthcare Investors from $39.00 to $42.00 and gave the stock a "sector perform" rating in a report on Thursday, August 28th. Finally, Truist Financial lifted their price target on Omega Healthcare Investors from $39.00 to $44.00 and gave the stock a "hold" rating in a report on Wednesday, September 3rd. Six equities research analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the company. Based on data from MarketBeat, the company currently has an average rating of "Moderate Buy" and a consensus target price of $44.38.

Omega Healthcare Investors Profile

Omega Healthcare Investors, Inc engages in the provision of financing and capital to the long-term healthcare industry with a particular focus on skilled nursing facilities, assisted living facilities, independent living facilities, rehabilitation and acute care facilities, and medical office buildings.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.